Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: Soliris TM
Active ingredients: eculizumab
What it is used for
For the treatment of patients with paroxysmal nocturnal haemoglobinuria (PNH) to reduce haemolysis. Atypical haemolytic uraemic syndrome (aHUS).
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Intravenous Infusion
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Shake
- Shelf lifetime is 30 Months.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
30 mL of clear colourless liquid contained in a labelled, 30 mL glass vial
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November 1, 2018. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient eculizumab
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
Soliris Concentrated solution for infusion - myDr.com.au
Soliris Concentrated solution for infusion - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Department of Health | Australia New Zealand Therapeutic Products Agency (ANZTPA)
On 20 June 2011, the Australian and New Zealand Prime Ministers announced their agreement to proceed with a joint scheme for the regulation of therapeutic products across both countries.
Read more on Department of Health website
Top results
